# OnCo record paper-rtog-1016-lancet-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-rtog-1016-lancet-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-rtog-1016-lancet-2019" ;
  schema:name "NRG Oncology RTOG 1016: radiotherapy plus cetuximab versus cisplatin in HPV-positive oropharyngeal cancer"@en ;
  schema:description "Trying to reduce toxicity by swapping cisplatin for cetuximab during radiotherapy in HPV-positive oropharyngeal cancer backfired: cetuximab gave worse survival and more recurrences with no reduction in toxicity, so cisplatin remains standard."@en ;
  schema:url <https://onco.cc/key-papers/paper-rtog-1016-lancet-2019/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0140-6736(18)32779-X>, <https://pubmed.ncbi.nlm.nih.gov/30449625/> ;
  schema:sameAs <https://doi.org/10.1016/S0140-6736(18)32779-X> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Gillison ML, Trotti AM, Harris J, et al." ;
  onco:cancers <https://onco.cc/cancers/hpv-positive-oropharyngeal-cancer/>, <https://onco.cc/cancers/oropharyngeal-cancer/> ;
  onco:drugs <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/cisplatin/> ;
  onco:trials <https://onco.cc/trials/rtog-1016/> ;
  onco:journals <https://onco.cc/journals/lancet/> .